176 related articles for article (PubMed ID: 28551847)
21. Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma.
Nizamutdinov D; Stock EM; Dandashi JA; Vasquez EA; Mao Y; Dayawansa S; Zhang J; Wu E; Fonkem E; Huang JH
World Neurosurg; 2018 Jan; 109():e67-e74. PubMed ID: 28951270
[TBL] [Abstract][Full Text] [Related]
22. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
Molitoris JK; Rao YJ; Patel RA; Kane LT; Badiyan SN; Gittleman H; Barnholtz-Sloan JS; Bentzen SM; Kruser TJ; Huang J; Mehta MP
J Neurooncol; 2017 Sep; 134(2):331-338. PubMed ID: 28643151
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
24. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
Guthrie GD; Eljamel S
J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
[TBL] [Abstract][Full Text] [Related]
25. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
26. Impact of gender on the survival of patients with glioblastoma.
Tian M; Ma W; Chen Y; Yu Y; Zhu D; Shi J; Zhang Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305382
[No Abstract] [Full Text] [Related]
27. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism (VTE) and glioblastoma.
Yust-Katz S; Mandel JJ; Wu J; Yuan Y; Webre C; Pawar TA; Lhadha HS; Gilbert MR; Armstrong TS
J Neurooncol; 2015 Aug; 124(1):87-94. PubMed ID: 25985958
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
[TBL] [Abstract][Full Text] [Related]
30. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
[TBL] [Abstract][Full Text] [Related]
31. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
32. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
34. Distress persists in long-term brain tumor survivors with glioblastoma multiforme.
Keir ST; Farland MM; Lipp ES; Friedman HS
J Cancer Surviv; 2008 Dec; 2(4):269-74. PubMed ID: 18958627
[TBL] [Abstract][Full Text] [Related]
35. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
Czarnek N; Clark K; Peters KB; Mazurowski MA
J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
[TBL] [Abstract][Full Text] [Related]
36. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
37. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
[TBL] [Abstract][Full Text] [Related]
38. Conditional probability of long-term survival in glioblastoma: a population-based analysis.
Johnson DR; Ma DJ; Buckner JC; Hammack JE
Cancer; 2012 Nov; 118(22):5608-13. PubMed ID: 22569786
[TBL] [Abstract][Full Text] [Related]
39. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
40. Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?
Goda JS; Lewis S; Agarwal A; Epari S; Churi S; Padmavati A; Gupta T; Shetty P; Moiyadi A; Jalali R
Clin Neurol Neurosurg; 2015 Aug; 135():46-53. PubMed ID: 26038275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
